Vyome Holdings, Inc. (HIND)
NASDAQ: HIND · Real-Time Price · USD
2.160
-0.140 (-6.09%)
Jun 5, 2026, 4:00 PM EDT - Market closed
Vyome Holdings Revenue
Vyome Holdings had revenue of $31.59K in the quarter ending March 31, 2026, a decrease of -84.09%. This brings the company's revenue in the last twelve months to $152.72K, down -59.66% year-over-year. In the year 2025, Vyome Holdings had annual revenue of $319.71K with 24.43% growth.
Revenue (ttm)
$152.72K
Revenue Growth
-59.66%
P/S Ratio
99.26
Revenue / Employee
$10,909
Employees
14
Market Cap
15.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 319.71K | 62.77K | 24.43% |
| Dec 31, 2024 | 256.94K | -159.00K | -38.23% |
| Dec 31, 2023 | 415.94K | 33.08K | 8.64% |
| Dec 31, 2022 | 382.87K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionHIND News
- 4 days ago - Vyome Holdings Earnings Call Transcript: Q1 2026 - Transcripts
- 4 days ago - Vyome Holdings Quarterly report: Q1 2026 - Filings
- 4 days ago - Vyome Holdings Earnings release: Q1 2026 - Filings
- 10 days ago - Vyome reports Q1 EPS (15c) vs. ($761.59) last year - TheFly
- 10 days ago - Vyome Holdings Reports First Quarter 2026 Results With Key FDA Filings and Strong Balance Sheet - Business Wire
- 26 days ago - Vyome signs exclusive license agreement with Impetis - TheFly
- 26 days ago - Vyome Strikes Deal With Impetis Biosciences, Opening A ~$57B Market Opportunity - Business Wire
- 4 weeks ago - Vyome initiated with a Buy at Litchfield Hills - TheFly